Infinium Pharmachem has announced a board meeting to consider the financial results for the quarter and half-year.

The company has entered a 5-year exclusive distribution agreement with Japan's K Sakai & Company, a well-established chemical distributor with a strong presence in semiconductors, electronics, pharmaceuticals, and agrochemicals.

This partnership aims to expand Infinium’s iodine derivatives market in Japan, targeting high-purity specialty chemical demand in semiconductor and electronics sectors, potentially boosting future revenues and global reach.